Vivid mental imagery occurs frequently in schizophrenia spectrum disorders (SSDs). Overlapping phenomena, such as obsessions or ruminations, are also frequent in other psychiatric disorders, raising significant diagnostic challenges. Unfortunately, contemporary operational psychopathology lacks the epistemological and phenomenological framework to address such questions. Using the resources of phenomenology and philosophy of mind, we articulate the structure of imagination and describe its distinctive modifications in the SSDs. Drawing on pilot data with patients' self-descriptions, we present the notion of perceptualized imagery. The anomalous imagery acquires spatialization, spatiotemporal constancy, explorability, autonomy and a sense of experiential distance between the subject and the image. As a quasi-perceptual, stable object, such imagery often evokes an intense affective response, whereas the normal sense of ‘irreality' of the fantasy may become compromised. We articulate these anomalies of imagination as being entailed by the underlying generative disorder of schizophrenia, namely the disorder of minimal self (unstable ipseity or first-person perspective). We propose that pathology of imagination is an important psychopathological aspect of the schizophrenia spectrum, with significant relevance for early diagnosis and differential diagnosis.

1.
Parnas J, Sass LA, Zahavi D: Rediscovering psychopathology: the epistemology and phenomenology of the psychiatric object. Schizophr Bull 2013;39:270-277.
2.
Bleuler E: Dementia Praecox or the Group of Schizophrenias. New York, International University Press, 1950.
3.
Jaspers K: General Psychopathology. Chicago, University of Chicago Press, 1963.
4.
Ey H: Traité des hallucinations. Paris, Masson, 1973.
5.
Hoch P, Polatin P: Pseudoneurotic forms of schizophrenia. Psychiatr Q 1949;23:248-276.
6.
Parnas J, Henriksen MG: Disordered self in the schizophrenia spectrum: a clinical and research perspective. Harv Rev Psychiatry 2014;22:251-265.
7.
Nelson B, Parnas J, Sass LA: Disturbance of minimal self (ipseity) in schizophrenia: clarification and current status. Schizophr Bull 2014;40:479-482.
8.
Henriksen MG, Parnas J: Clinical manifestations of self-disorders and the gestalt of schizophrenia. Schizophr Bull 2012;38:657-660.
9.
Parnas J, Jansson L, Sass LA, Handest P: Self-experience in the prodromal phases of schizophrenia: a pilot study of first admissions. Neurol Psychiatry Brain Res 1998;6:107-116.
10.
Parnas J, Moller P, Kircher T, Thalbitzer J, Jansson L, Handest P, et al: EASE: Examination of Anomalous Self-Experience. Psychopathology 2005;38:236-258.
11.
Rasmussen AR, Parnas J: Pathologies of imagination in schizophrenia spectrum disorders. Acta Psychiatr Scand 2015;131:157-161.
12.
Husserl E: Phantasy, Image Consciousness, and Memory, 1898-1925. Dordrecht, Springer, 2005.
13.
Casey ES: Imagination, phantasy, hallucination and memory; in Philips J, Morley J (eds): Imagination and Its Pathologies. Cambridge, MIT Press, 2003, pp 65-92.
14.
Husserl E: Cartesian Meditations. The Hague, Nijhoff, 1965.
15.
Warren ND: Husserl and the Promise of Time: Subjectivity in Transcendental Phenomenology. Cambridge, Cambridge University Press, 2009.
16.
Sartre J-P: The Imaginary: A Phenomenological Psychology of the Imagination. London, Routledge, 2010.
17.
Zahavi D: Subjectivity and Selfhood: Investigating the First-Person Perspective. Cambridge, MIT Press, 2005.
18.
Nordgaard J, Parnas J: Self-disorders and the schizophrenia spectrum: a study of 100 first hospital admissions. Schizophr Bull 2014;40:1300-1307.
19.
Sass LA, Parnas J: Schizophrenia, consciousness, and the self. Schizophr Bull 2003;29:427-444.
20.
Parnas J, Sass L: The structure of self-consciousness in schizophrenia, in Gallagher S (ed): The Oxford Handbook of the Self. Oxford, Oxford University Press, 2011, pp 521-546.
21.
Sass L: Explanation and description in phenomenological psychopathology. J Psychopathol 2014;20:366-376.
22.
Parnas J: A disappearing heritage: the clinical core of schizophrenia. Schizophr Bull 2011;37:1121-1130.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.